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Abstract
Marystella Tomoe Takahashi1, Henrique Faria Ramos2, Carlos Diógenes Pinheiro-Neto3, Ivan Dieb Miziara4, 
Reynaldo Ayer de Oliveira5 
1 Otorhinolaryngologist, Collaborating Physician from the Group of Voice - ENT Division - University Hospital - Medical School of the University of São Paulo.
2 Otorhinolaryngologist, Preceptor - Department of Otorhinolaryngology - University Hospital - Medical School of the University of São Paulo.
3 Otorhinolaryngologist; Graduate Student - Department of Otorhinolaryngology - University Hospital - Medical School of the University of São Paulo.
4 Associate Professor - Medical School of the University of São Paulo, Head of the Stomatology Group - Department of Otorhinolaryngology - University Hospital - Medical School of 
the University of São Paulo and Full Professor of Forensic Medicine and Medical Deontology - FMABC.
5 PhD in Pathology - State University of São Paulo - Júlio de Mesquita Filho, UNESP. PhD, Professor of Bioethics - Department of Forensic Medicine, Medical Ethics, Social Medicine 
and Occupational Medicine - Medical School of the University of São Paulo.
Otorhinolaryngology Program - University Hospital - Medical School of the University of São Paulo.
Send Correspondence to: Marystella Tomoe Takahashi - R. Otávio Nébias 98 ap. 121 Vila Mariana São Paulo SP 04002-010.
Paper submitted to the BJORL-SGP (Publishing Management System – Brazilian Journal of Otorhinolaryngology) on December 16, 2009; 
and accepted on January 3, 2010. cod. 6846
in the last decades, medical care has been increasingly permeated by the concept of evidence-
based-medicine, in which clinical research plays a crucial role in establishing diagnostic and treatment. 
Following the improvements in clinical research, we have a growing concern and understanding that 
some ethical issues must be respected when the subjects are human beings. research with human 
subjects relies on the principles of autonomy, beneficence, no maleficence and justice. Ordinance 
196/96 from the national Health Board adds to the Brazilian legislation such renowned bioethical 
principles.
Aim: discuss the main ethical aspects involved in research with human subjects.
Materials and Methods: Critical analysis of Ordinance 196/96 and related literature.
Conclusion: Ordinance 196/96 rules research with human subjects; nevertheless, it requires more 
in-depth discussions regarding the informed consent, use of placebo, research with vulnerable 
populations and research in developing countries.
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first rules to govern research done with human beings. 
Among these rules, there is the need for a voluntary 
consent from the participant, prior studies in labs and 
with animals, and the analysis of risk and benefits that 
investigation could bring about, the individual’s freedom 
to withdraw at any time from the study and the proven 
qualification of the researchers to do the study, among 
other issues7.
in 1964, during the 18th World Medical Assembly, 
the nuremberg Code was revised and the declaration of 
Helsinki was approved, which also established the rules 
for combined clinical research with professional care and 
clinical research without treatment goals8, and until current 
days it is recommended in the legislation of numerous 
countries and submitted to constant reviews. in the Bel-
mont report of 1979, for the first time it was established the 
basic ethical principles of respecting people, beneficence 
and justice in the ethical make up of research.
Based on the creation of such documents, there 
was a growing internationalization of the methodological 
standards and legislative proliferation and standards, con-
cerned with matching, in practice, individual’s ethics with 
knowledge, the rights of mankind with social well-being5. 
during the 80’s, a more elaborate document was created on 
the subject, called: “international Guidelines for Biomedical 
research with Human Beings”. These regulatory standards 
are based on the subject of the study receiving and unders-
tanding information concerning the study, followed by his/
her consent; the researcher’s obligations; the protection of 
vulnerable groups or those with reduced autonomy such 
as children, people with mental or behavioral disorders, 
prisoners, individuals from underdeveloped communities 
and pregnant women; in the constitution and responsibility 
of ethical review committees9.
in Brazil, it was only in 1988 that we had the first 
guidelines regulating experimentation with human beings, 
through Ordinance 01/88. in 1995, the national Health Bo-
ard (nHB) decided to review it, with the goal of updating it 
and fill out the blanks generated by scientific development. 
The new resolution was created through an exemplary 
process of participatory construction, by a group made up 
of representatives from numerous social and professional 
areas, counting on the support of physicians, theologians, 
jurists, biologists, business people and representatives of 
the users. Ordinance 196/96 from the nHB adds to the 
Brazilian legislation the internationally accepted bioethical 
principles of autonomy, beneficence, no maleficence and 
justice, and it is based on the aforementioned documents, 
as well as in the proceedings from the Constitution of the 
Federative republic of Brazil, from 1988 and the associa-
ted Brazilian legislation, here the Consumers’ Code, Civil 
and penal Codes, the Statute of Children and Adolescents, 
and others. Thus, it aims at guaranteeing rights and duties 
concerning the scientific community, and regarding the 
INTRODUCTION
in 1971, American oncologist Van renssealer potter 
used for the first time the term bioethics1. Considering our 
scientific and technological progress, moral dilemmas and 
the transformations we’ve had in the social and political 
scenarios during the 60’s and the 70’s, all aimed at pro-
moting a new dialogue between science and humanism2, 
stirring a debate about normative and applied ethics3 
through a new discipline which would associate biological 
knowledge (bio) with human values (ethics)1.
Bioethics consolidation happened in 1979, with the 
book Principles of Biomedical Ethics, in which its guiding 
principles were established: autonomy, beneficence, no 
maleficence and justice4. Autonomy is associated with the 
right each person has to self-governing, which from the 
practical standpoint is translated into the patient’s consent 
to participate in the proposed medical procedures. Bene-
ficence and no maleficence correspond to the Hippocratic 
principles of doing good (bonum facere) and, first of all, 
not harming (primun non nocere), alluding to the need 
of always seeking the well-being and taking care of the 
interventions. Justice is the principle of equity, in which 
the equal must be treated equally and the unequal must 
be treated in an unequal fashion3.
These principles are still valid. The contemporary 
bioethics scenario is based on an ethics in which there is 
a balance between respect for people and the demands 
of investigation, between respect for individual values and 
the interest for the collective5.
OBJECTIVE
The goal of the present traditional review paper is 
to discuss the main ethical aspects involved in research 
with human beings.
MATERIALS AND METHODS
The authors made a critical analysis of codes of 
bioethics, focusing of Ordinance 196/96 from the national 
Board of Health and correlate literature.
DISCUSSION
in recent decades, medical care has been increasin-
gly permeated by this concept of evidence-based medicine, 
in which clinical research plays a crucial role in establishing 
diagnostic and treatment guidelines. With the progress of 
clinical research, we started having the concern and the 
understanding that certain ethical standards must be obser-
ved when the goal of the study involves human beings6.
in 1947, with the recognition of the so-called “crimes 
against humanity” perpetrated during the Second World 
War, the nuremberg Code was created, establishing the 
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cause vulnerability contribute to prevent free choice11.
And why does vulnerability represent a concern in 
bioethics? One possible answer is that vulnerable indivi-
duals or groups of individuals are subject to exploitation. 
On the other hand, actions geared towards protecting vul-
nerable people may be seen as paternalistic, and therefore 
be challenged by the very group which it is intended to 
protect. patients with chronic diseases or disabilities may 
have a drop in their self-esteem, making them fragile 
and, therefore, vulnerable, subject to making emotional 
decisions, instead of rational ones12, and under a situation 
of dependence from the researchers and the institution 
end up waiving their self-determination. The situation 
of individuals in our country is also concerning, because 
without true access to health care, often times they seek 
to participate in studies as a means to obtain access to 
medical care8.
One issue in the Ordinance that deserves further 
consideration is that it is prohibited to provide any form of 
compensation to the participating individuals, although it is 
allowed to compensate for all expenses. nonetheless, the 
Ordinance is vague in relation to which expenses may be 
compensated. Would compensation for the inconvenience 
and the time spent be included in this reimbursement? Or 
only expenditures with transportation or food? in some 
cases, such as those involving economically less fortunate 
individuals, compensation may be used to persuade indivi-
duals to participate in the study against their best judgment 
(“excessive induction”)9. According to Charlesworth, those 
economically less fortunate have reduced autonomy, since 
“nobody is able to develop their personal freedom when 
they are stressed by poverty, stricken from basic education 
or if they live without public order “13.
in an effort for such rules to be complied with, it is 
mandatory for one to present the research project before 
the ethics in research Committee of the institution. The 
different training and competence of the individual mem-
bers of the ethics Committee, including representatives 
from different fields of knowledge, representatives from 
users, illustrates the trend that well-educated decisions 
must be made about the experiment to be led by the 
entire society. Thus, there is an attempt to eliminate from 
the pure medical-scientific ground the judgment on the 
morality of biomedical investigation5.
Coordinating the set, there is the national Com-
mittee of ethics in research (COnep), which acts as a 
normative body, of resource and coordination, and it is 
responsible for approving and creating complementary 
standards in theme areas such as human genetics, human 
reproduction, research with indian populations, research 
with foreign cooperation, research involving biosafety, 
research with new equipment and procedures which 
acceptance is still not widely accepted in the literature.
subjects of the study and the state10.
resolution 196/96 from the nHB stresses that “every 
procedure, of whichever nature involving humans beings, 
which acceptance is not yet established in the scientific 
literature, will be considered research” and that “all re-
search projects involving human beings involve risk”, 
either directly or indirectly. The research’s subject has a 
right to full medical care and indemnity, should he/she 
suffer any type of damage (moral, physical, psychological, 
intellectual, social, cultural or spiritual) arising from the 
study, which must be immediately terminated should any 
risk or damage be foreseen to the health of the subject 
participating in the study, consequent to it, not covered in 
the informed consent form. By the same token, as soon as 
the superiority of one method is established over another 
method, the research must be terminated, offering all sub-
jects the best treatment regimen. At the end of the study, 
the subjects of the study must receive the same benefits 
arising from the project, in terms of social return, access 
to procedures, products or agents from the study.
The bioethical principle of autonomy can be mate-
rialized in the need for obtaining a free and informed con-
sent form, a document in which the individual expresses 
his/her authorization to freely participate in the research. 
in obtaining such approval, the individuals must be fully 
briefed in an accessible language, with a clear exposure 
of the existing alternative methods; discomforts and any 
possible and expected risks and benefits; assurance of 
confidentiality, secrecy and privacy; freedom to refuse 
to participate or withdraw his/her consent at any time 
during the study without any penalty or loss; means of 
compensation.
The attempt to protect vulnerable groups deserve 
special attention, advocating that research must be done 
with individuals under full autonomy, ruling out possibi-
lities of dependence, subordination, coercion or intimida-
tion. According to the Ordinance, vulnerability is defined 
as “the state of people or groups that for any reason or 
motive have their self-determination capacity reduced, 
especially in regards of the informed consent form”.
Ordinance 196/96 considers synonymous the con-
ditions of reduced autonomy and vulnerability. According 
to Guimarães & novaes11, the terms are different, because 
a reduction in autonomy, being transitional, definitive or 
voluntary, is associated with a person and it is not extensive 
to a group, because the expression of freedom is stated 
in the informed consent, given by each subject individu-
ally. The vulnerable individuals are people that because 
of their social, cultural, ethnicity, political, economic, and 
educational or health situations have their differences es-
tablished among them and society turned into inequality, 
which impairs their capacity to freely express their will. The 
exacerbation of vulnerability causes the reduction or total 
loss of individual freedom, because the same factors which 
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CONCLUSION
despite the implementation of Ordinance 196/96 
and international regulatory standards, there still are some 
ethical issues, especially in regards of the informed consent 
form, the use of placebo, the participation of people under 
vulnerability and doing research in developing countries.
The informed consent is often times seen as a mere 
bureaucracy, of responsibility exemption, when the true 
intent of the document is the protection of freedom and 
the dignity of the subjects of the study8. Concerning the 
use of placebo, vulnerability and research being done in 
developing countries, such topics make up constant objects 
of discussion, especially due to the pressure of pharma-
ceutical giants and foreign researchers, owing to future 
updates of the declaration of Helsinki and Ordinance 
196/96 to uphold and comply with rights and to respect 
the individuals involved in the study.
The current Brazilian document is not statutory or 
code and, even not being a law, it carries legal force, being 
consistent enough to be flexible with responsibility. in 
short, ethics in research with humans does not work as a 
road map; it only guides the principles of autonomy, bene-
ficence, no maleficence and justice, just like a compass14.
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